Rebecca Torguson, MPH

Division Director
FDA
Silver Spring, Maryland, United States

No relationships to disclose

Presentation(s):

• SESSION I: SELECTED WORKING GROUP UPDATES & FOCUS 2024

  Saturday, March 9, 2024
  1:05 PM – 2:05 PM ET

• Discussion Panel

  Saturday, March 9, 2024
  1:45 PM – 2:05 PM ET

• Registry-Supported Trial Operations

  Saturday, March 9, 2024
  4:45 PM – 5:55 PM ET

• Overview Discussion, Comments & Next Steps

  Saturday, March 9, 2024
  6:40 PM – 7:00 PM ET

• Panel Discussion: Leveraging Real-World Evidence: Where Are We Now and What Lies Ahead?

  Tuesday, March 12, 2024
  10:02 AM – 10:30 AM ET